StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX – Free Report) to a sell rating in a report published on Monday morning.
Separately, HC Wainwright reaffirmed a “buy” rating and set a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Aemetis presently has an average rating of “Moderate Buy” and a consensus target price of $12.95.
Read Our Latest Stock Analysis on Aemetis
Aemetis Stock Up 2.2 %
Aemetis (NASDAQ:AMTX – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) earnings per share. Research analysts anticipate that Aemetis will post -2.07 EPS for the current fiscal year.
Institutional Trading of Aemetis
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers grew its position in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after acquiring an additional 50,528 shares during the period. Susquehanna Fundamental Investments LLC boosted its position in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after purchasing an additional 93,536 shares in the last quarter. FMR LLC grew its holdings in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. State Street Corp increased its position in shares of Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares in the last quarter. Finally, Wellington Management Group LLP acquired a new position in shares of Aemetis during the 3rd quarter worth approximately $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Read More
- Five stocks we like better than Aemetis
- Where to Find Earnings Call Transcripts
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Pros And Cons Of Monthly Dividend Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Plot Fibonacci Price Inflection Levels
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.